from    
to    
search  

 


集成电路系列学术邀请报告第05期: A Fully Immersible Digital Deep-Brain Probe ...
第十届形式语言学国际研讨会
世纪物理情系列讲座(第25讲)Space-time group and dynamic crystal
【学术论坛报名】首届清华大学-美团数字生活联合研究院学术论坛——大模型时代下的智...
报告题目:
Development and Production of Human Biotherapeutics
 报告人:
James Leung
Visiting Scientist 

Biology department & Center for Biomedical Innovations,MIT
报告时间:
2010-03-02 10:30
报告地点:
化学工程系(工物馆 324-东 会议室)
主办单位:
化学工程系
  简介:

Dr. Leung is a Visiting Scientist at MIT participating in biotechnology research projects in the Biology and Chemical Engineering departments. He also engages with biotechnology and pharmaceutical companies by serving as consulting advisor in the areas of biotherapeutic development and manufacturing.

 

For the last ten years, Dr. Leung was the Vice President of Biotechnology at Ipsen, an international pharmaceutical company headquartered in France and the United Kingdom. Prior to Ipsen, from 1995 to 1998, he worked as an independent consultant advising startup biotechnology companies in the United States and Asia, and served as industrial coordinator for two consortia at MIT – BioProcess Engineering Center (BPEC) and Consortium for the Advanced Manufacturing of Pharmaceuticals (CAMP). From 1993 to 1995, Dr. Leung was the Senior Vice President of Operations at Repligen Corp., a public biotechnology company focused on developing novel therapeutics for neurological disorders. Dr. Leung started his biotechnology career at Genentech, Inc.

 

Dr. Leung received a B.Sc. degree from the Chemical Engineering Department at MIT, and a M.Sc. degree and a Ph.D. degree in biochemical engineering from MIT.

今日相关信息
中国发展道路研讨会暨《中国向何处去》和《...
 
同类别相关信息
Large Scale Computing in Computatio...
清华论坛第51期:积极应对气候变化 努...
WORKING WITH CHINESE MEDIA, AN ANGL...
清华论坛第50期:150 Years of Mathem...
清华论坛第50期:Reaching for Einste...
学术活动